Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Cara Therapeutics (CARA)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 669,895
  • Shares Outstanding, K 39,290
  • Annual Sales, $ 910 K
  • Annual Income, $ -58,130 K
  • 36-Month Beta 2.87
  • Price/Sales 73.43
  • Price/Cash Flow N/A
  • Price/Book 4.35

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 8 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/18
See More
  • Average Estimate -0.59
  • Number of Estimates 6
  • High Estimate -0.49
  • Low Estimate -0.74
  • Prior Year -0.43
  • Growth Rate Est. (year over year) -37.21%

Price Performance

See More
Period Period Low Period High Performance
1-Month
14.10 +20.92%
on 01/29/19
17.11 -0.35%
on 02/08/19
+1.85 (+12.17%)
since 01/15/19
3-Month
12.19 +39.87%
on 12/24/18
19.19 -11.15%
on 11/16/18
-1.71 (-9.12%)
since 11/15/18
52-Week
11.46 +48.78%
on 04/04/18
24.30 -29.84%
on 09/21/18
+2.21 (+14.89%)
since 02/15/18

Most Recent Stories

More News
Consolidated Research: 2019 Summary Expectations for Tenaris S.A, Rapid7, Halozyme Therapeutics, Cara Therapeutics, EnPro Industries, and K12 -- Fundamental Analysis, Key Performance Indications

In new independent research reports released early this morning, Market Source Research released its latest key findings for all current investors, traders, and shareholders of Tenaris S.A. (NYSE:TS),...

CARA : 17.05 (+3.02%)
RPD : 45.94 (-2.38%)
LRN : 32.06 (+0.25%)
NPO : 72.21 (+4.20%)
HALO : 17.04 (+3.02%)
TS : 26.81 (+2.33%)
Biotech Plays in the News You Should Know

HENDERSON, NV / ACCESSWIRE / February 12, 2019 / Below are several companies in the biotech space that are making news and drawing investor interest. These companies have the potential to make investors...

CRON : 21.29 (+2.26%)
CARA : 17.05 (+3.02%)
PTI : 4.07 (-1.69%)
Shares of Immunogen Inc Rank the Highest in Terms of Relative Performance in the Biotechnology Industry (IMGN , CARA , RDUS , PTLA , MNTA )

Here are the top 5 stocks in the Biotechnology industry ranked by performance. We compiled the trading activity from yesterday and then analyzed the industry looking for stocks that were outperforming....

CARA : 17.05 (+3.02%)
RDUS : 18.29 (+3.45%)
IMGN : 5.65 (+2.91%)
These 4 Marijuana Stocks Are Looking Strong

CORAL GABLES, FL / ACCESSWIRE / February 8, 2019 / The market has managed to flourish over the last few years, despite the fact that cannabis itself remains illegal under federal law as a Schedule I narcotic....

CARA : 17.05 (+3.02%)
GTBIF : 13.5000 (-0.27%)
Watch These Marijuana Stocks Hit The Ground Running On Wednesday (2/6/19)

CORAL GABLES, FL / ACCESSWIRE / February 6,2019 / have had quite a solid weeks during the beginning of February. Companies in the sector have enjoyed significant movement due to major legislative changes...

CARA : 17.05 (+3.02%)
ITHUF : 5.5006 (+4.77%)
POTND : 0.0200 (+32.45%)
HIPH : 0.0540 (-1.82%)
IAN.CN : 7.290 (+4.74%)
Biotech Stocks to Watch

HENDERSON, NV / ACCESSWIRE / February 5, 2019 / In January, the trend in biotech stocks appeared to be on a positive sloping trajectory as the IBB capped off its strongest month in almost a year. Below...

CRON : 21.29 (+2.26%)
CARA : 17.05 (+3.02%)
DCTH : 0.3089 (+0.10%)
EYEN : 4.73 (-6.15%)
Cannabis and Biotech Stocks that Could Explode

HENDERSON, NV / ACCESSWIRE / January 29, 2019 / Small cap securities in the biotechnology industry are always of interest to investors because several events can help increase the stock's share price at...

ACB : 7.05 (-0.70%)
CARA : 17.05 (+3.02%)
CLDX : 5.86 (+13.35%)
Biotech Stocks to Watch this Week

HENDERSON, NV / ACCESSWIRE / January 28, 2019 / Biotech can be a lucrative sector for investors. Companies in the industry are often working toward well-defined goals such as clinical trial results, which...

CARA : 17.05 (+3.02%)
INSY : 4.96 (+3.77%)
XXII : 2.55 (+1.19%)
Consolidated Research: 2019 Summary Expectations for First Data, IDEXX Laboratories, CMS Energy, Worthington Industries, Triumph Group, and Cara Therapeutics -- Fundamental Analysis, Key Performance Indications

In new independent research reports released early this morning, Market Source Research released its latest key findings for all current investors, traders, and shareholders of First Data Corporation (NYSE:FDC),...

CARA : 17.05 (+3.02%)
FDC : 25.58 (+2.20%)
TGI : 23.24 (+0.74%)
CMS : 52.77 (+0.51%)
IDXX : 210.26 (+1.60%)
WOR : 37.68 (+0.21%)
Shares of Biogen Inc Rank the Highest in Terms of Relative Performance in the Biotechnology Industry (BIIB , CARA , LOXO , CELG , GILD )

Below are the top five companies in the Biotechnology industry as measured by relative performance. This analysis was compiled based on yesterday's trading activity as we search for stocks that have the...

CARA : 17.05 (+3.02%)
LOXO : 234.80 (+0.06%)
BIIB : 332.87 (+2.51%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 48% Buy with a Strengthening short term outlook on maintaining the current direction.

Longer term, the trend strength is Average.

The market is approaching overbought territory. Be watchful of a trend reversal.

See More Share

Trade CARA with:

Business Summary

Cara Therapeutics, Inc. is a biopharmaceutical company. The company is focused on developing and commercializing new chemical entities designed to alleviate pain. Cara Therapeutics, Inc. is based in Shelton, United States.

See More

Key Turning Points

2nd Resistance Point 17.43
1st Resistance Point 17.24
Last Price 17.05
1st Support Level 16.69
2nd Support Level 16.33

See More

52-Week High 24.30
Fibonacci 61.8% 19.40
Fibonacci 50% 17.88
Last Price 17.05
Fibonacci 38.2% 16.36
52-Week Low 11.46

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar